Investor Relations
Latest Financial Results
Q1 2022
Quarter Ended Mar 31, 2022
Latest 10-K
View Latest 10-KStock Information
Symbol
Nasdaq: AVCOPrice
Change
Volume
52 week Low/High
Day Low/High
Company Overview
Avalon GloboCare Corp. (NASDAQ: AVCO) is a global intelligent biotech developer and healthcare service provider dedicated to advancing cell-based technologies and therapeutics, with a focus on developing and empowering innovative and transformative cell-based technologies and their clinical applications. In addition, Avalon provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth, development, as well as competitiveness in both the domestic and global healthcare markets. Through its subsidiaries, namely GenExosome Technologies Inc. and Avactis Biosciences Inc., Avalon is establishing a leading role in the fields of exosome-based diagnostics, cellular immunotherapy (including CAR-T/CAR-NK), and regenerative medicine.
Avalon GloboCare Investor Presentation May 2022
Investor Contact Information
Company
Avalon GloboCare Corp.
4400 Route 9 South
Suite 3100
Freehold, NJ 07728
Investor Relations
Crescendo Communications, LLC
T: (212) 671-1020
avco@crescendo-ir.com
Transfer Agent
VStock Transfer LLC
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436
info@vstocktransfer.com
www.vstocktransfer.com
